Ciena reports strong revenue growth, but earnings miss expectations as networking segment leads while routing declines, with management setting a 14% revenue target for fiscal 2025.
Shari Redstone, Paramount's chair, battles thyroid cancer as the company navigates a merger with Skydance and a lawsuit by former President Trump.
Ciena reports strong revenue growth, but earnings miss expectations as networking segment leads while routing declines, with management setting a 14% revenue target for fiscal 2025.
Shari Redstone, Paramount's chair, battles thyroid cancer as the company navigates a merger with Skydance and a lawsuit by former President Trump.